• Esco Medical collaborates with Poland-based deeptech company MIM Fertility to integrate AI software into the MIRI® TL Incubator.
  • Offering flexibility, Esco Medical empowers IVF clinics and labs to choose AI-driven solutions tailored to their unique needs.

LITHUANIA, 20 January 2025 – Esco Medical proudly announces a new partnership with MIM Fertility, a Poland-based deeptech innovator specializing in AI solutions for IVF clinics and laboratories. This partnership further demonstrates our commitment to integrating our products with cutting-edge technologies like artificial intelligence.

Through this collaboration, MIM Fertility’s flagship AI tool, EMBRYOAID®, will be featured in Esco Medical’s MIRI® TL Incubators to evaluate the implantation potential of human embryos using a single image or time-lapse video. The advanced AI and machine learning algorithms will streamline fertility workflows, improve treatment efficiency, and enhance patient outcomes.

“We are thrilled to partner with MIM Fertility. By incorporating their powerful AI/ML platform, EMBRYOAID®, into our MIRI® TL Incubators, we can drive precision improvements and revolutionize fertility clinic workflows,” said Juan Jiménez, Global Head of Sales and Marketing for Esco Medical.

“We are thrilled to partner with Esco Medical,” said Ula Sankowska, CEO of MIM Fertility. “By integrating EMBRYOAID’s advanced AI-driven insights with Esco’s MIRI® Time-Lapse Incubator, we empower embryologists to enhance accuracy and make more data-informed decisions throughout the IVF process. This collaboration sets a new standard in fertility treatment, combining cutting-edge AI technology with state-of-the-art incubation systems to deliver exceptional outcomes for patients.”

Esco Medical remains committed to fostering innovation and providing flexible solutions that empower fertility clinics to optimize workflows and personalize care. Together with MIM Fertility, we aim to transform embryo assessment, advance reproductive health, and pave the way for a brighter future in fertility treatment.